Patrick Soon-Shiong
Pharmaceuticals · United States
Net worth, last 30 days
Biography
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.
He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.
He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.
He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.
He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.
In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
Did you know
Soon-Shiong graduated from high school at age 16 and became a doctor at 23.
Soon-Shiong was born in South Africa to Chinese immigrants.
Holdings
| Company | Ticker | Shares | Value |
|---|---|---|---|
| Allscripts | MDRX-US | 3,071,000 | $15M |
| Benitec Biopharma | BNTC-US | 293,000 | $2.4M |
| Bristol-Myers Squibb Co. | BMY-US | 8,155,296 | $476M |
| Celgene Corporation | CELG-US | 0 | $0 |
| Contingent Value Rights for Celgene Corporation | CELGZ-US | 0 | $0 |
| Directa Plus | DCTA-GB | 0 | $0 |
| ImmunityBio Inc | IBRX-US | 648,994,010 | $4.3B |
| ImmunityBio Inc | IBRX-US | 900,000 | $5.9M |
| JAKKS Pacific Inc. | JAKK-US | 0 | $0 |
| Liminal BioSciences | LMNL-CA | 0 | $0 |
| NantHealth | NHIQ-US | 0 | $0 |
| RadNet Inc. | RDNT-US | 561,000 | $39M |
| Sorrento Therapeutics | SRNE-US | 0 | $0 |
| Tribune Publishing | TPCO-US | 0 | $0 |
| Private assets & other | $4.5B | ||